Olivegrades

ONS ONCC CHEMO RENEWAL QUESTIONS & ANSWERS || 2025 LATEST UPDATE || VERIFIED COMPLETE PACKAGE DEALONS ONCC CHEMO RENEWAL QUESTIONS & ANSWERS || 2025 LATEST UPDATE || VERIFIED COMPLETE PACKAGE DEALONS ONCC CHEMO RENEWAL QUESTIONS & ANSWERS || 2025 LATEST UPDATE || VERIFIED COMPLETE PACKAGE DEALONS ONCC CHEMO RENEWAL QUESTIONS & ANSWERS || 2025 LATES

The standard states that gowns must: A. be disposable B. not have any closures or seams that HDs can pass through C. be changed every shift if there are no specific manufacturer recommendations D. both a & b - ANSWER D. both a & b Which of the following is the only time that a verbal order should be accepted with regards to chemotherapy and biotherapy treatment? A. Decrease in the dose

When chemotherapy is used before primary treatment (surgery) to reduce the size of a solid tumor, it is called what? - ANSWER Neoadjuvant Therapy Which of the following class of drugs is cell cycle non-specific and therefore can affect the cancer in any phase of the cell cycle? - ANSWER Alkylating Agents Mutations in genetic material from exposure to chemotherapy are termed? - ANSWER Genotoxicity The Vinca Alkaloids act in which phase where they prevent

Hematologic cancer (blood cancer) - ANSWER -cancer that begins in bone marrow or immune system cells. -Ex: leukemia, lymphoma, multiple myeloma Leukemia - ANSWER cancer starts in blood-forming tissues like bone marrow -causes lots of abnormal blood cells to be produced and enter bloodstream Lymphoma - ANSWER -cancer that begins in immune system (WBC=lymphocytes) -hodgkin and non-hodgkins -B lymphocytes (B cells) - make antibodies (bacteria

Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It only changes the timing of treatment and can change surgical options if the tumor is shrunk enough. If this occurs, the patient may only require a lumpectomy plus radiation therapy instead of needing a mastectomy - ANSWER Main benefit of neoadjuvant chemotherapy (breast cancer patient) A comprehensive geriatric assessment (CGA) is a multidisciplinary evaluation to assess life expectancy and risk of morbidity ...

Verification of Treatment as Planned - ANSWER -vascular access device appropriate for treatment plan -will patient adhere to plan -is the treatment plan appropriate for patient -do additional referals need to be made for treatment -is there evidenced based rationale for treatment -is the drug a vesicant and are there safety precautions in place -is the drug a cumulative lifetime dose limit and is there tracking in place Patient education - ANSWER -assess pt's readiness to learn, hea...

vesicants - ANSWER bleomycin, carmustine, cisplatin, daunorubicin, doxorubicin, etposide, idarubicin, melphalan, taxol, vincristine cisplatin antidote - ANSWER sodium thiosulfate doxorubicin antidote - ANSWER Dexrazoxane vincristine antidote - ANSWER hyaluronidase

Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It only changes the timing of treatment and can change surgical options if the tumor is shrunk enough. If this occurs, the patient may only require a lumpectomy plus radiation therapy instead of needing a mastectomy - ANSWER Main benefit of neoadjuvant chemotherapy (breast cancer patient)

G1 - ANSWER first growth phase (or first gap) 2 - ANSWER How many cells are produced each time a cell divides? mitosis - ANSWER the process of cell division

Alkylating agents - ANSWER Classification Break DNA helix strand, thereby interfering with DNA replication Altretamine (Hexalen) - ANSWER Alkylating Agent PO Ovarian CA Side effects- nausea, vomiting, skin rash, hypersensitivity reaction, diarrhea Dose limiting - neuro-toxicity, peripheral neuropathy, myelosuppression Bendamustine (Treanda/Bendeka) - ANSWER Alkylating agent IV CLL or Indolent NHL Side effects- pyrexia, nausea, vomiting, skin reactions, TLS, hepatotoxicity, vein irr...